A Multi-centre Observational Study to Describe Usage and Dosification Patterns of RoActemra (Tocilizumab) Treatment in Rheumatoid Arthritis (RA) Patients in the Routine Clinical Practice. ACT-LIFE Study.

Trial Profile

A Multi-centre Observational Study to Describe Usage and Dosification Patterns of RoActemra (Tocilizumab) Treatment in Rheumatoid Arthritis (RA) Patients in the Routine Clinical Practice. ACT-LIFE Study.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Sep 2015

At a glance

  • Drugs Tocilizumab (Primary)
  • Indications Rheumatoid arthritis
  • Focus Adverse reactions
  • Acronyms ACT-LIFE
  • Sponsors Roche
  • Most Recent Events

    • 23 May 2013 Actual initiation date changed from Nov 2012 to Aug 2012 as reported by ClinicalTrials.gov.
    • 23 May 2013 Actual initiation date changed from Aug 2010 to Jul 2010 as reported by ClinicalTrials.gov.
    • 06 Jul 2012 Actual patient number 400 added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top